2025 Translational Research Grants in Brain Cancer

Brain Canada is teaming up with the Cancer Research Society (CRS) and the Kindred Foundation to launch the 2025 Translational Research Grants in Brain Cancer. A national program to fund translational research that advances effective translation and application of knowledge of brain cancer across the expanse of pre-clinical, clinical and health services delivery domains to improve patient outcomes. 

This funding program is intended to provide opportunities for multi-disciplinary collaborations between basic researchers and clinicians to translate research into novel approaches for the study, diagnosis and/or treatment of pediatric or adult brain cancer. 

This competition has an overall envelope of $2,000,000 CAD to support up to two grants of $1,000,000 CAD each, over up to three years, funded by Brain Canada and Cancer Research Society.

An additional grant may be awarded to a research proposal focused on pediatric and young adult diffuse low-grade glioma, should such a proposal be ranked in the top three. This grant would be funded in collaboration between Brain Canada, Cancer Research Society, and Kindred Foundation.

Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation and creativity. Brain Canada, Cancer Research Society, and Kindred Foundation are committed to excellence through equity, and we encourage applicants of diverse backgrounds to apply to our funding opportunities. 

Click here to view the Request for Applications. 

Deadline for Receipt of the Registration Form: May 8, 2025 at 17:00 ET 

Deadline for receipt of Full Applications: June 23, 2025 at 17:00 ET